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It has been amply demonstrated that an inhibition of the development of 
experimental  cholesterol atherosclerosis  occurs in cholesterol-fed rabbits that 
have been previously rendered diabetic with alloxan. In the original study of 
this subject Duff and McMillan (1) reported on the effects of feeding cholesterol 
to diabetic,  to normal, and to "alloxan-recovered" rabbits. The last were ani- 
mals that had been  injected with alloxan,  had become  diabetic for a  short 
time, and had almost completely recovered from the effects of the alloxan be- 
fore they were fed cholesterol. It was argued that since both the diabetic rab- 
bits and the "aUoxan-recovered"  animals had received the same intravenous 
dose of alloxan, the inhibitory effect on the development of cholesterol athero- 
sclerosis observed in the diabetic rabbits only was not dependent on the alloxan 
per se nor on its possible effects on organs or tissues other than the pancreatic 
islets. At the same time, however, it was recognized that the argument was not 
perfect since it could well be maintained that the "alloxan-recovered" animals 
were less susceptible to the general effects of alloxan than the diabetic animals 
as indicated by the very fact that permanent diabetes failed to develop  in 
them. However, the "alloxan-recovered"  rabbits were regarded, at least tenta- 
tively, as providing a suitable control of the effects of alloxan injection, per se. 
Subsequent  studies have  contributed to  an  appreciation of some  of the 
mechanisms that may be involved in the inhibition of atherosclerosis in alloxan- 
diabetic rabbits (2, 3) but the question of whether the inhibitory effect is asso- 
ciated with the alloxan itself or with the induced diabetic state has not been 
completely resolved. Recently, Cook, Mills, and Green (4) have reported that 
the effects of alloxan on tissues other than the pancreas do not protect against 
experimental  cholesterol  atherosclerosis.  The  experiments  reported here  de- 
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scribe the effects of treatment of the alloxan-diabetic state with insulin in rab- 
bits fed cholesterol. They establish that, if the metabolic disturbances asso- 
ciated with the diabetic state are  mitigated by treatment with insulin, the 
inhibitory effect of alloxan diabetes on the development of cholesterol athero- 
sclerosis is minimized. Together with the findings of Cook et al. they establish 
that the inhibitory effect is associated with the diabetic state and not with 
other effects of the injection of alloxan. 
EXPF.I~rM'ENTAL 
Two separate but similar  experiments were undertaken. 
~#~imen~  l.--Sixty-eight  white rabbits of both sexes  were studied.  The animals each 
weighed about 2 kilos  at the beginning of the experiments. Their exact ages were unknown. 
The rabbits  were allowed to become accustomed to the rabbit  house during a period of pre- 
lhninary study. Their food consisted of a commercial rabbit  chow and water ~  fixture. 
Blood was drawn from a cut through the central  artery  and veins of the ear for analysis  of 
its  normal concentration of cholesterol  and sugar.  The concentration of free  and total  cho- 
lesterol  in the serum was determined by the Schoenheimer-Sperry method (5);  the concen- 
tration of sugar in the blood was determined by a modification of Folin's  micro method 
(6).  These analyses were repeated at biweekly intervals  throughout the duration of the ex- 
periment. 
When the animals had attained a weight of about 2.5 kilos,  they received intravenously 
an injection  of alioxan monohydrate. The alloxan  was prepared freshly  as a 5 per cent m/~ 
solution  in distilled  water. It was administered into  the lateral  vein of the ear in a dose of 
200 reg./kilo  of body weight as rapidly  as possible  through a 20 gauge needle.  A total  of 50 
animals were injected with alloxan. 
Six hours after receiving alloxan the rabbits were given 20 gm. of dextrose in 100 cc.  of 
water by stomach tube. They received no other treatment whatsoever, but were allowed to 
stabilize their  metabolism for a  period of about 1  month.  During this time  many rabbits 
died in diabetic coma and some recovered from the diabetic state that had followed the 
injection of alloxan. 
Following the period of metabolic stabilization, the diabetic rabbits were placed  in me- 
tabolism cages for 7 to 10 days. Observations were made daily on the 24 hour urine volume, 
food intake, weight, and total urinary glucose excretion. Urine volume was determined to 
the nearest 5 cc., food consumption to the nearest 5 gin., weight to the nearest i00 gin., and 
glucose excretion was measured by Benedict's quantitative method and spot-tested with a 
commercial preparation. 
On the completion of the preliminary period of observation the surviving diabetic ani- 
mals and 18 non-diabetic control rabbits were fed cholesterol. Cholesterol was fed by stom- 
ach tube daily at midday as a  5 per cent solution in warm corn oil. Fifteen cc. of oil con- 
raining 0.75  gin.  of  cholesterol was  administered daily.  There  occurred  a  brief period  of 
marked anorexia of 4  to 6  days duration following the initiation of cholesterol feeding. As 
soon as the diabetic rabbits had recovered their appetite, insulin therapy was begun.  Prota- 
mine zinc insulin, 40 units per cc., was injected daily at 9 a.m. beneath the skin of the  back. 
The individual doses of insulin were empirical and were determined largely by the glycosuria 
observed on spot testing the urine.  The persistence of a  minor amount of glycosuria was 
considered to indicate the desired therapeutic effect.  The food intake of the animals was 
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the diabetic animals were studied dally with respect to the volume of urine excreted,  the 
urinary glucose, food intake, and body weight.  The duration of cholesterol feeding varied 
from 57 to 90 days. 
The surviving animals were killed and autopsied.  Various tissues were examined micro- 
scopically.  The  heart  and  aorta  were  removed  together,  opened,  fixed  in  formalin,  and 
stained en bloc in sudan IV. The location and size of sudanophilic intimai lesions of the aorta 
were charted graphically and graded on a scale of 0 to 4 in accordance with the scheme illus- 
trated by Duff and McMilian (1).  Grade 0  indicated no atherosclerosis while grade 4  de- 
noted extensive and severe intimal lesions. The aorta was then coiled longitudinally, em- 
bedded, and sectioned in such a  way that a  single microscopic section included the whole 
length of the vessel. 
Experiment 2.--The procedures and materials of Experiment 1 were employed in Experi- 
ment 2.  Certain changes and additions to the methods were introduced.  Three groups  of 
animals were studied: (1)  diabetic, cholesterol-fed, and insulin-treated rabbits; (2)  diabetic, 
cholesterol-fed animals; and  (3)  non-diabetic, cholesterol-fed rabbits. All animals were fe- 
male. In addition to studies of the blood glucose and serum cholesterol, determinations of 
the serum lipid phosphorus (7) and total fatty acids (8) were made and the fatty acids of 
neutral fat were calculated (9). 
During a period of 3 months 74 rabbits were injected with alloxan. Of these, 16 survived, 
maintained diabetic blood sugar levels in excess of 300 mg. per cent, and completed the ex- 
periment. Ten of the diabetic rabbits were fed cholesterol and treated with insulin while 6 
were fed cholesterol but were not treated.  Thirteen normal control  animals weighing ap- 
proximately 2.5 kilos were fed cholesterol also. 
The feeding of cholesterol to all three groups of rabbits was initiated on the same day. 
The rabbits were fed  100 gin.  of commercial chow coated with 1 gin.  of cholesterol. The 
cholesterol was added to the food as a  10 per cent w/v solution in ethyl ether. It was rapidly 
and uniformly mixed with the food pellets which were then allowed to dry until the odor of 
ether was lost.  One hundred gin.  of  cholesterolized food was given to  each rabbit every 
morning. Every evening the diabetic, insulin-treated rabbits were given a  large dish of un- 
adulterated food while the diabetic, untreated rabbits and control rabbits were given 50 gin. 
of food that did not contain cholesterol. The daily intake of cholesterolized and cholesterol- 
free food was measured. 
Insulin treatment was begun the day before cholesterol feeding was initiated. Protamine 
zinc insulin was employed once or twice daily, morning and evening, for the first 17 days; 
thereafter protamine zinc insulin and  crystalline insulin were given daily in  the morning 
only. 
The  duration  of  the experiment was  76  days  of cholesterol feeding.  During this time 
samples of blood for lipid analysis were drawn on days 12, 32, 53, and 74 from the diabetic 
rabbits. The non-diabetic control animals had blood drawn for cholesterol analyses on the 
same  days,  but lipid phosphorus and fatty acid  analyses were done on day  74 only. The 
degree of lipemia in the serum was graded visually on an arbitrary scale of 0 to 4. The con- 
tent of sugar in the blood of the diabetic rabbits was determined weekly. Daily quantitative 
analyses of the sugar excreted in the urine were made. 
OBSERVATIONS 
Experiment /.--Experimental  mortality was severe.  Of 50 rabbits injected 
with alloxan only 6 frankly diabetic rabbits completed the experiment. Of the 
42 rabbits that died, 20 suffered fatal diabetic coma, 2 had fatal insulin  shock, 
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miscellaneous causes including infection. Nine of 18 non-diabetic control rab- 
bits died. Six aspirated oil during feeding, 2 developed a  fatal diarrhea during 
feeding, and the cause of death was not determined in 1 rabbit. 
The observations made on the surviving rabbits are summarized in Table I. 
TABLE I. 
Summary of Experimental Data. Experiment I 
Rabbit 
No. 
B-50 
C-44 
C-45 
C-57 
C-3 
C-2 
C-54 
D-12 
D-15 
D-13 
D-f1 
A-37 
A-78 
A-74 
A-73 
.~  .~.~ 
rE 
57 
rE 
rE 
rE 
rE  73 
['E 
9O 
8 
o  >o 
gm.  ~ni~ 
37  5.0 
40  -- 
37 
42  2.5 
50  2.1 
49  1.8 
42  0.8 
45  -- 
46 
48 
49 
631  4.0 
64[  -- 
64 
63 
kg. 
2.7 
~.7 
2.~ 
2.4 
3.2 
3.~ 
2.( 
2.8 
3.1 
3.1 
2A 
3.( 
3.1 
el  ~,l o 
kg.  gin. 
3 ,¢  38.4 
3A  -- 
3.~  -- 
2.~"  21.7 
3A  22.2  [ 
3A  22.0 
2A  25.1 
3.¢  -- 
4.1  -- 
3A  -- 
4.1  -- 
3.¢  25.O 
4.~  -- 
5.:  -- 
3.!  -- 
~o~  ~'~ ~ 
~..~ 
gm. 
.0.0 
8.5 
8.2 
3.7 
3.5 
o.51 
--  I 
o 
mg. 
per 
135 
119 
142 
98 
233 
258 
266] 
1691 
2471 
2671 
258 
28~ 
14~ 
104 
27~ 
o 
0..4 
trig. 
per 
ceng 
368  1.0 
34810.2 
373  1.0 
268  0.4 
667  I 0.8 
737  ] 1.G 
795  [ 1.2 
450  [ 0.8 
700  I o.~ 
J 
683  I 2.1 
343  10.8 
351  10.~ 
593  1.1 
0-.4 
1 (trace) 
1 
* TD, insulin-treated diabetic rabbits; C, untreated, non-diabetic control rabbits. 
There were 3  separate series of animals of experimental duration of 57,  73, 
and  90  days respectively. All of the diabetic rabbits excreted more  than  20 
gm. of glucose daily in the urine before insulin therapy was begun. Following 
the use of from 0.8 to 5.0 units of insulin daily, the daily glucose excretion was 
diminished on  the  average  from  61  to 98  per  cent. The  insulin  dosage  and 
the diminution of glycosuria were  not  closely correlated but  displayed great 
individual variation. Two of the treated diabetic rabbits lost a  small amount 
of  weight  during  the  experiment,  one  gained  slightly,  and  the  remaining  3 
rabbits gained a  moderate amount of weight during the experiment. The non- 
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with  insulin.  The lipemic index and  the  concentration of cholesterol in  the 
serum tended to be slightly higher in the treated diabetic rabbits than in the 
control rabbits. It was noted that, with one exception, lipemia did not appear 
in the serum of the insulin-treated diabetic rabbits with unusual rapidity. The 
serum of rabbit A-37, which had the highest lipemic index, also tended to mani- 
fest quickly its lipemic state in vitro. 
The differences in the severity of atherosclerosis of the aorta in the control 
and in the insulin-treated diabetic animals were no greater than might be en- 
countered in groups of normal rabbits fed cholesterol for the same periods of 
time. 
Experiment  2.--Tbe  experimental mortality among  the  animals  rendered 
diabetic with alloxan was severe. Seventy-four animals received one or more 
injections of alloxan. Of these, 58 died, while 16 were diabetic and completed 
the  experiment. Fifty-one of the rabbits died before cholesterol feeding and 
insulin treatment were begun and of these 32 died during the first 6 days fol- 
lowing the injection of alloxan. The experimental observations are summarized 
in Table II. 
Nine of the 10 diabetic rabbits that were subsequently treated with insulin 
excreted daily more than 25 gin. of sugar in the urine. The tenth animal (G-41) 
was ill and anoretic at the time the pretreatment glycosuria was studied so 
that the value observed (an average daily excretion of 11.0 gin.) was not repre- 
sentative. With insulin treatment a good control of the diabetic state was ob- 
tained. The average reduction in glucose excretion was not less than 87.6 per 
cent, and in one animal it was as much as 95 per cent. The group average daily 
excretion of glucose in the urine fell from 35.5 gin. to 3.2 gin. during treatment 
with insulin. The untreated diabetic rabbits lost an average of 70 gin. in body 
weight, while the treated diabetic rabbits gained  1.03 kilos and the non-dia- 
betic rabbits gained 1.12 kilos. 
It was observed that, on the average, the untreated, cholesterol-fed diabetic 
rabbits had the greatest, the insulin-treated, cholesterol-fed diabetic rabbits had 
less, and the non-diabetic, cholesterol-fed rabbits had the least concentration 
of cholesterol in the serum. These differences were not striking. The serum lipid 
phosphorus values obtained from the untreated,  cholesterol-fed diabetic ani- 
mals were double those observed in the non-diabetic, cholesterol-fed control 
rabbits and were six or seven times normal. The serum total cholesterol/lipid 
phosphorus ratio of the non-diabetic rabbits was 18.1; in the treated diabetics 
it was 16.3,  and in the untreated diabetic animals it was 10.4. A normal ratio 
in the rabbit maintained on a cholesterol-free diet is approximately 10.4 in this 
laboratory. The serum fatty acids of neutral fat of the untreated diabetic rabbits 
were markedly elevated. The average content of triglyceride in the serum was 
approximately 2.5 gin. per cent. This figure included one animal with an average 
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TABLE  II 
Summary of Ex~erimenta~ Data. Experiment 2 
.~o~  .~  o  °  ~  "~  ._ 
he  o~  °" ~  o  ~a  ~"~ 
heo  ~  a 
I-4 
rag.  rag.  rag.  m.eq/ 
days  gin. unils  kg.  kg.  gin.  gra.  per  per  per  liter  0-4  0-4 
vent  Cent  Cenl 
F-20  TD*  76  76  17.7  3.86  4.70  48.6  4.8  209  525  25.1  35.5  1.8  3 
E-70  TD  76  76  17.0  3.27  4.49  55.5  4.7  44  165  15.0  8.8  0.3  1 
F-12  TD  76  76  12.8  4.16  5.30  35.4  4.4  94  278  27.3  13.1  0.3  1 
F-2  TD  76  76  8.2  3.04  4.10  28.9  3.6  257  520  43.7  23.1  1.8  2 
F-I  TD  76  76  15.2  2.58  3.52  37.7  3.3  232  551  39.4  30.2  2.0  2 
E-74  TD  76  75  11.7  3.75  5.20  24.8  2.9  205  542  34.9  10.3  2.5  3 
D-99  TD  76  76  10.6  4.13  5.27  26.6  2.4  291  678  26.2  32,0  1.8  3 
G-41  TD  76  76  10.7  3.56  5.11  --  2.3  156  401  21.8  12.5  0.5  2 
E-43  TD  76  76  4.6  4.67  5.15  25.3  2.0  191  465  34.4  24.8  1.5  3 
E-65  TD  74  72  10.8  3.22  3.69  36.8  1.8  170  456  13.6  18.7  0.8  2 
E-73  UD  76  76  --  3.05  3.15  47.3  --  161  363  58.0  90.2  2.5  1  (trace) 
G-t0  UD  76  76  --  3.58  4.01  26.7  --  136  412  55.0  55.8  1.5  1 
F-21  UD  76  73  --  3.06  2.51  35.8  --  185  487  24.1  38.9  1.5  1 
E-66  UD  76  76  --  3.59  3.72  32.6  --  175  529  35.0  19.3  2.5  2 
F-14  UD  76  76  --  2.70  2.19  43.7  --  269  539  72.6  293.2  4.0  1  (trace 
G-11  UD  76  75  --  3.52  3.47  19.4  --  302  570  33.2  36.2  2.5  2 
H-76  C  76  76  --  3.31  4.64  -- 
H-79  C  76  69  --  3.26  4.28  -- 
H-77  C  76  76  --  2.75  4.25  -- 
H-78  C  76  69  --  2.95  4.34  -- 
G-80  C  76  76  --  2.24  4.14  -- 
0-39  C  76  75  --  2.94  3.75  -- 
G-82  C  76  75  --  2.91  4.98  -- 
G-90  C  76  75  --  3, 29  4.83  -- 
G-84  C  76  76  --  3.29  4.08  -- 
G-81  C  76  74  --  3,51  4.11  -- 
G-83  C  76  75  --  3.68  4.45  -- 
G-87  C  76  71  --  3,54  4,53  -- 
G-88  C  76  74  --  2,57  3.61  -- 
--  30  91  7.2  5.7  0.3  1 (trace) 
--  94  174  16.9  29.9  0.5  1 
--  84  242  20.2  13.4  0.8  1 
--  102  289  17.3  18.4  0.8  1 
--  127  432  45.7  29.2  1.3  2 
--  174  438  26.1  20.9  1.3  2 
--  189  459  17.0  15.1  1.5  3 
--  221  488  13.3  22.1  1.8  3 
--  222  524  20.0  31.1  2.5  4 
--  232  530  25.5  30.2  1.8  3 
--  230  548  25.3  16.1  2.5  4 
--  231  598  25.4  30.0  2.0  3 
--  293  643  41.0  26.4  2.5  3 
Means 
TD ...............  11.9  I  3.62  4.65 
UD .......  --  3.25  3.18 
C.  ..  3.09  4.31 
35.5  3.2 
~.3  -- 
185  458 
205  483 
172  420 
28.1  20.9 
46.3  88.9 
23.2  22.2 
1.3 
2.4 
1.5 
* TD,  insulin-treated  diabetic  rabbit;  UD,  untreated  diabetic  rabbit;  C,  untreated  non-diabetic  control 
rabbit. 
exceptional quantity is omitted, the average serum triglyceride of the untreated 
diabetic rabbits was about 1.5  gin. per cent or double that of either the dia- 
betic rabbits treated with insulin or the non-diabetic rabbits. It was also ob- 
served  that  the  serum  of  the  untreated  diabetic  rabbits  was  visibly more 
lipemic than  that  of either  the  treated  diabetic  or non-diabetic rabbits.  In- G.  L.  DUFF,  D.  J.  H.  BRECHIN,  AND  W.  E.  ]~INKELSTEIN  377 
deed,  the latter  two groups manifested about  the  same intensity of visible 
lipemia. 
In the untreated diabetic group, lesions of grade 1 severity were observed 
in 4 animals (67  per cent), 2 of which had lesions of minimal degree; lesions 
of grade 2 severity were found in 2 rabbits (33 per cent). The non-diabetic rab- 
bits manifested lesions of grade 1 severity in 4  (31 per cent), grade 2 in 2 (15 
per cent), grade 3 in 5 (38 per cent), and grade 4 in 2 (15 per cent). On the 
other hand, among the insulin-treated diabetic rabbits, aortic atherosclerosis 
of grade 1 severity was observed in 2 (20 per cent), of grade 2 in 4 (40 per cent), 
and of grade 3 in 4 (40 per cent). Thus, while the atherosclerosis of the aorta 
observed in the untreated diabetic rabbits was of slight degree, that found in 
the non-diabetic control animals and in the treated diabetic rabbits was con- 
siderably more extensive. The difference between the severity of atherosclerosis 
in the two last groups, while not negligible, was of minor degree. 
DISCUSSION 
The experiment reaffirms that atherosclerosis of the aorta develops in much 
less marked degree in rabbits rendered diabetic with alloxan and fed choles- 
terol than in non-diabetic rabbits fed cholesterol in a  similar way. The large 
content of cholesterol and especially of lipid phosphorus and neutral fat previ- 
ously observed in the serum of cholesterol-fed diabetic rabbits was observed 
again. It may be noted that the untreated diabetic animals in the present ex- 
periment, unlike those previously reported (1, 2,  10), were not fed additional 
vegetable oil with the cholesterol-enriched diet. 
The development of experimental cholesterol atherosclerosis was inhibited 
in the diabetic rabbits but not in the diabetic rabbits that were treated with 
insulin.  However,  while  insulin  treatment,  which  was  accompanied  by  an 
amelioration of the diabetic state, permitted the development of severe athero- 
sclerosis  of the aorta, the lesions did not develop quite as freely, either in size 
or extent, as in the non-diabetic control animals. At the same time, the con- 
trol of the diabetic state attained by insulin treatment as judged by the asso- 
ciated decrease in glucose excretion was never perfect. A  residual glycosuria 
persisted in every case. It seems reasonable to suggest that the failure to attain 
complete control of the diabetic state in the insulin-treated diabetic rabbits 
accounts for the slight discrepancy in the severity of the atherosclerosis ob- 
served in them as compared with the non-diabetic controls. From the experi- 
mental data it is concluded that the inhibition of the development of experi- 
mental  atherosclerosis  in  rabbits  rendered  diabetic  with  aUoxan  and  fed 
cholesterol is associated with some factor or factors of the diabetic state and 
is not due to the alloxan per se or to its effects on organs or tissues other than 
the pancreatic islets. 
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responsible for the inhibitory effect. It has been suggested that it may be due 
to  the  unusual serum  cholesterol/lipid phosphorus ratio  and  serum neutral 
fat content of the diabetic rabbits (2), to weight loss or failure to gain weight 
(11, 12), or to the unusual serum lipoprotein spectrum observed in cholesterol- 
fed diabetic rabbits  (3). 
Duff and Payne (2)  observed that alloxan-diabetic rabbits fed cholesterol 
developed a  pronounced hyperphospholipidemia and a  large concentration of 
neutral fat in the serum as well as a marked hypercholesterolemia. The serum 
cholesterol/phospholipid ratio and the serum cholesterol/neutral fat ratio in 
the diabetic rabbits fed cholesterol were less abnormal in the diabetic than in 
the non-diabetic cholesterol-fed animals, and they suggested that the inhibi- 
tory effect in hypercholesterolemic animals depended upon the maintenance of 
relatively normal serum lipid ratios. In a subsequent experiment utilizing the 
surface-active agent tween 80 they obtained evidence that the ratio of serum 
cholesterol to lipid phosphorus might be closely allied to the inhibitory effect 
while that between serum cholesterol and neutral fat was not (15). The present 
data disclosed that  the  serum cholesterol/lipid phosphorus ratio was about 
normal in the diabetic rabbits,  but was considerably larger than normal in 
the insulin-treated diabetic rabbits and even larger in the non-diabetic rabbits. 
Therefore, there was a parallelism between the inhibition of the development 
of atherosclerosis and  the  relative normality of the  serum  cholesterol/lipid 
phosphorus ratio. A less regular relationship was found between the ratio of 
serum  cholesterol/neutral  fat  and  the  development  of  atherosclerosis.  The 
diabetic rabbits tended to have even lower ratios than normal while the insulin- 
treated rabbits had slightly higher ratios than the non-diabetic cholesterol-fed 
control rabbits.  The  data are  compatible with the  hypothesis of Duff and 
Payne (2) but they do not bring any new evidence of importance to bear on 
the problem. 
The data disclose that the untreated diabetic animals generally lost a small 
amount of weight while the treated diabetic and non-diabetic control rabbits 
generally gained about 1 kilo. The control rabbits gained slightly more weight 
than the insulin-treated diabetic animals. Therefore, there was a  parallelism 
between weight loss or failure to gain weight and the inhibition of the develop- 
ment of atherosclerosis in the diabetic rabbits. However, it is our opinion that 
this correlation merely represents a concommitant variation and is not a causal 
relationship. In their original paper, Duff and  McMillan (1)  considered the 
relationship  of body weight and the inhibition of atherosclerosis in  alloxan- 
diabetic rabbits. They concluded by the analysis of arrayed data that the in- 
hibitory effect was not due to variations in body weight. Subsequently, First- 
brook reported an experiment (11,  12)  in which cholesterol-fed rabbits were 
deliberately undernourished so that they did not gain weight normally. It was 
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sequent weight  loss  or failure to gain  weight inhibited  the  development of 
atherosclerosis (13). It was suggested (11,  12) that the weight loss associated 
with the diabetic state was responsible for the inhibitory effect observed by 
Duff and McMillan (1). Recently we have restudied the hypothesis that weight 
loss  inhibits  the  development of  experimental cholesterol atherosclerosis in 
undernourished rabbits (14). From the results of this study it was concluded 
that weight loss or the failure to gain weight in groups of undernourished choles- 
terol-fed rabbits does not cause them to develop less atherosclerosis than groups 
of adequately nourished control animals  fed the  same  daily dose of choles- 
terol, although it does result in a more pronounced hypercholesterolemia in the 
smaller, undernourished rabbits than in the larger control animals. 
It is apparent that insulin treatment has greatly ameliorated the diabetic 
state in all of its aspects that were observed in this experiment. The excretion 
of large amounts of sugar in the urine, the weight loss, the hypercholesterolemia, 
hyperphospholipidemia, and excess of fat in the serum that were observed in 
the untreated, cholesterol-fed, diabetic rabbits were all reduced in amount by 
insulin  therapy so that  the  animals  were more nearly like  the non-diabetic 
cholesterol-fed rabbits in these respects. At the same time the development of 
aortic atherosclerosis that attended cholesterol feeding in the insulin-treated 
diabetic rabbits also approximated that found in the non-diabetic control ani- 
mals. The experiment does not offer evidence that permits the analytical as- 
sociation of the observed individual components of the diabetic state with the 
inhibition  of the  development of experimental aortic  atherosclerosis in  the 
alloxan-diabetic rabbit  fed  cholesterol. 
Together with the observations of Cook and associates (4) the experimental 
data establish unequivocally that the inhibitory effect on the development of 
experimental  cholesterol atherosclerosis observed in  alloxan-diabetic  rabbits 
is due to the action of alloxan on the pancreatic islets with a resulting diabetic 
state and not due to any other possible action of the injected alloxan. 
S~rM~.RY 
Experiments were undertaken to ascertain whether the previously demon- 
strated inhibition of the development of experimental aortic atherosclerosis in 
alloxan-diabetic rabbits fed cholesterol was due to the injection of alloxan per 
se or to the existence of the diabetic state produced by alloxan. 
It was established that, by treating the diabetic state with insulin, the dia- 
betic state could be ameliorated and the inhibitory effect obviated. It was there- 
fore concluded that the inhibitory phenomenon was not due to the injection of 
alloxan per se but that it was associated with one or more factors that char- 
acterize the alloxan diabetic state in the rabbit and that are reversible by in- 
sulin therapy. 
In the course of the experiment it was demonstrated that the inhibitory ef- 380  ALLOXAN  DIABETES  AND  ATHEROSCLEROSIS.  IV 
fect was apparent in cholesterol-fed diabetic rabbits whether or not their diet 
was supplemented with vegetable oil. The previously reported metabolic ab- 
normalities of the diabetic animals were confirmed. It was established that suit- 
able treatment of the cholesterol-fed diabetic animals with insulin would bring 
all the metabolic aberrations, including those of the serum lipids, into reason- 
ably  close  correspondence  with  those  observed  in  non-diabetic  rabbits  fed 
cholesterol. 
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